Health care industry sues over another transparency rule
Health care groups don't want transparency that reveals true prices. More
Higher Prices for Cancer Surgery at National Cancer Institute–Designated Cancer Centers
The National Cancer Institute (NCI) Cancer Centers Program, developed as part of the National Cancer Act of 1971, recognizes 71 cancer centers across the US that meet rigorous standards for transdisciplinary and innovative research to develop new and better approaches to preventing, diagnosing, and treating cancer. Although this program was developed to advance cancer research, these cancer centers have an important role in translating scientific knowledge into effective treatments for patients with cancer. Moreover, these cancer centers, nearly all part of academic medical centers, attract top clinician researchers and clinician educators who seek to advance both cancer research and clinical care. More
Private Equity Drills into the Dental Care Industry
DSOs are overwhelmingly owned by private equity firms. 27 of the top 30 DSOs are private-equity-owned. This amounts to approximately 84% of practice locations that contract with the top 30 DSOs. More
Americans’ Medical Debts Are Bigger Than Was Known, Totaling $140 Billion
A new study finds that health care has become the country’s largest source of debt in collections. Those debts are largest where Medicaid wasn’t expanded. More
Speaking Out Against Aggressive Medical Debt Collection Practices
Medical debt and collection actions further perpetuate racial inequities by limiting economic opportunities and further contributing to the wealth divide. More
Biden admin releases first rule banning surprise medical bills
The Biden administration released the first part of regulations to implement a law that bans surprise medical bills, outlining what types of charges will be outlawed starting in 2022. More
Health insurers are threatening not to cover some patients’ ER bills
Plans like United Healthcare say it’s necessary to contain health care costs. Experts say it’s the wrong approach. More
Will Biogen’s new Alzheimer’s drug’s burden on Medicare be big, huge, or catastrophic?
Estimates vary wildly about how much Biogen’s new Alzheimer’s drug will cost Medicare — and the total will have real consequences. More
New Drug Could Cost the Government as Much as It Spends on NASA
The Alzheimer’s treatment will cost $56,000 per patient, and millions may use it. The result: “crazy numbers” for Medicare. More
RIP Medical Debt Works with Ballad Health to Abolish Over $277M of Medical Debt
Ballad Health and RIP Medical Debt (RIP) announced today a new agreement that will eliminate $277,974,370.31 million worth of non-governmental payer medical debt (i.e., non-Medicare/Medicaid) for approximately 82,000 people previously served by Ballad Health. More